Induction of cancer cell apoptosis by α-tocopheryl succinate: Molecular pathways and structural requirements

FASEB Journal

Volumn 15, Issue 2, 2001, Pages 403-415

  Neuzil, Jirí ^a,g   Weber, Tobias ^a   Schröder, Andreas ^a   Lu, Min ^b   Ostermann, Georg ^a   Gellert, Nina ^a   Mayne, George C ^c   Olejnicka, Beata ^d   Negre Salvayre A ^e   Stícha, Martin ^f   Coffey, Robert J ^b   Weber, Christian ^a,g  

^a UNIVERSITY OF MUNICH   (Germany)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c FLINDERS UNIVERSITY   (Australia)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e INSERM   (France)

^f CHARLES UNIVERSITY   (Czech Republic)

^g Institute for Cardiovascular Diseases   (Germany)

Author keywords

Colon cancer; Programmed cell death; Protein kinase C; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; PROTEIN KINASE C;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ENZYME INHIBITORS; GENES, BCL-2; HUMANS; ISOENZYMES; JURKAT CELLS; KINETICS; MICE; MICE, NUDE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; TETRADECANOYLPHORBOL ACETATE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VITAMIN E;

TOSCANA VIRUS;

EID: 17744376942     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0251com     Document Type: Article

References (56)

1. Vitamin E: Antioxidant activity, biokinetics, and bioavailability
2. WAF1/CIP1 via C/EBPβ
3. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendo-theliosis virus transformed avian lymphoid cells
4. α-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation
5. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB
6. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
7. The molecular biology of apoptosis
8. Two CD95 (APO-1/Fas) signalling pathways
9. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes
10. Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector
11. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
12. d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties
13. The effects of α-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium
14. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation
15. The effects of α-tocopherol on critical cells in atherogenesis
16. α-tocopherol specifically inactivates cellular protein kinase Cα by changing its phosphorylation state
17. Evidence that protein kinase Cε mediates phorbol ester inhibition of calphostin C- and tumor necrosis factor-α-induced apoptosis in U937 histiocytic lymphoma cells
18. Activation of PKCα downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells
19. Loss of protein kinase C function induces an apoptotic response
20. Protein kinase C regulates Fas (CD95/APO-1) expression
21. Bcl-2 phosphorylation required for anti-apoptosis function
22. Ceramide induces Bcl-2 dephosphorylation via a mechanism involving mitochondrial PP2A
23. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21 (waf1/cip1) and p27 (kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells
24. Linking protein kinase C to cell-cycle control
25. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
26. MCF-7 breast cancer cells transfected with protein kinase Cα exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
27. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes
28. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
29. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
30. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells
31. Cellular injury induced by oxidative stress is mediated through lysosomal damage
32. 2 production and low density lipoprotein lipid oxidation
33. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase Cα expression
34. Analysis of the role of protein kinase C-α -ε, and -ζ in T cell activation
35. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis
36. phox membrane translocation and phosphorylation
37. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases
38. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis
39. Protein kinase C: Structure, function, and regulation
40. The extended protein kinase C superfamily
41. Induction of apoptosis through the PKC pathway in cultured dermal papilla fibroblasts
42. Selective inhibition of protein kinase C isozymes by Fas ligation
43. Inhibition of membrane lipid-independent protein kinase Cα activity by phorbol esters, diacylglycerols, and bryostatin-1
44. Evidence that the activation of an inactive pool of membrane-associated protein kinase C is linked to the IL-2-dependent survival of T lymphocytes
45. Involvement of protein kinase C delta (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCδ
46. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
47. Growth inhibition of MCF-7 and MCF-10A human breast cells by α-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs
48. α-tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-κB mobilization
49. Inhibition of NF-κB DNA binding activity by α-tocopheryl succinate
50. Ceramide inactivates cellular protein kinase Cα
51. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations
52. Multiple pathways control protein kinase C phosphorylation
53. Regulation of recombinant PKCα activity by protein phosphatase 1 and protein phosphatase 2A
54. The selective antiproliferative effects of a-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds
55. Vitamin E succinate induces apoptosis in human prostate cancer cells: Role for Fas in vitamin E succinate-triggered apoptosis
56. Vitamin E (d-α-tocopheryl succinate) decreases mitotic accumulation in gamma-irradiated human tumor, but not in normal, cells